Metis Lifesciences Private Limited
About Metis Lifesciences Private Limited
Data last updated:
Metis Lifesciences Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51101UP2016PTC076971.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Ratnakar Sharma (Managing Director) and Nirmala Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H/O Sudhandhu Kumar Ranjan Kh No. 554 H. No. 16 Sai Enclave Chipiyana Bujurag, Ghaziabad, Uttar Pradesh, India – 201009.
As per the financials filed for FY 2024, the company reported a revenue of ₹37.16 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹5,068 (net margin 0.1%) and EBITDA of ₹5,068 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 27% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Metis Lifesciences Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH/O Sudhandhu Kumar Ranjan Kh No. 554 H. No. 16 Sai Enclave Chipiyana Bujurag, Ghaziabad, Uttar Pradesh, India – 201009
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Metis Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Metis Lifesciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Metis Lifesciences Private Limited, buy the company report.
Financials of Metis Lifesciences Private Limited
FY 2025 filings availableMetis Lifesciences Private Limited reported revenue of ₹37.16 Lakh (down 23% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 23% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 27%. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5,068 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,068 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Metis Lifesciences Private Limited, buy the company report.
Board of directors of Metis Lifesciences Private Limited
Metis Lifesciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmala Devi | Director | 07 Mar 2016 | 10 Years 7 Months | Current |
| Ratnakar Sharma Also directs: Safecure Lifesciences Private Limited | Managing Director | 01 Jun 2025 | 1 Years 5 Months | Current |
Peer comparison
Metis Lifesciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Lifesciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jabh Pharmaceuticals Private Limited | ₹37.25 Lakh (FY 2024) | 36.0% | Delhi, India | |||
| Metis Lifesciences Private Limitedthis company | ₹37.16 Lakh (FY 2024) | ₹5,068 | 0.1% | -23.0% | Ghaziabad, Uttar Pradesh, India | |
| Cutichem Pharmaceutical Private Limited | ₹37.08 Lakh (FY 2025) | -73.0% | Gurgaon, Haryana, India | |||
| BLJ Pharmaceuticals Private Limited | ₹37.07 Lakh (FY 2025) | 1530.0% | Dadri, Uttar Pradesh, India |
To see the full peer comparison of Metis Lifesciences Private Limited, buy the company report.
Auditor
Metis Lifesciences Private Limited is audited by ALOK SRIVASTAVA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ALOK SRIVASTAVA & ASSOCIATES | FY 2022 | 015579C |
Shareholding
The shareholding of Metis Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Metis Lifesciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Metis Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Metis Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Metis Lifesciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Metis Lifesciences Private Limited has 5 board changes on record since 2016: 3 appointments and 2 cessations. The latest: Anil Sharma ceased to be Director on 01 Jun 2025.
Frequently asked questions
Metis Lifesciences is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 March 2016 (10+ years old) and is registered under CIN U51101UP2016PTC076971.
Metis Lifesciences has 2 current directors:
- Ratnakar Sharma - Managing Director
- Nirmala Devi - Director
The latest financial statements of Metis Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Metis Lifesciences is U51101UP2016PTC076971. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Metis Lifesciences was incorporated on 07 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Metis Lifesciences by revenue are Jabh Pharmaceuticals Private Limited, Cutichem Pharmaceutical Private Limited, BLJ Pharmaceuticals Private Limited, all in the Pharma industry (Lifesciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Anil Sharma ceased to be Director on 01 Jun 2025. Ratnakar Sharma was appointed as Managing Director on 01 Jun 2025. Ratnakar Sharma ceased to be Managing Director on 01 Mar 2018. Metis Lifesciences has 5 board changes on record in total.
The registered office of Metis Lifesciences is at HO Sudhandhu Kumar Ranjan Kh No. 554 H. No. 16 Sai Enclave Chipiyana Bujurag, Ghaziabad, Uttar Pradesh, India – 201009.
Metis Lifesciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Metis Lifesciences is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.
Metis Lifesciences can be reached at its registered office: HO Sudhandhu Kumar Ranjan Kh No. 554 H. No. 16 Sai Enclave Chipiyana Bujurag, Ghaziabad, Uttar Pradesh, India – 201009.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
